Clinical trial
A Gait and Path Tortuosity System for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
NCT07127133 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Gait and Path Tortuosity System for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
- Lead sponsor
- HealthPartners Institute
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 1, 2026
- Completion date
- August 31, 2027
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dementia, mild cognitive impairment (mci)